ISR CEO Mikael Brönnegård signing a MoU with Chairman of CRDGC Li Juan Jun in a meeting in Beijing April 7, 2017. For more information regarding CRDGC please click here.
ISR IMMUNE SYSTEM REGULATION HOLDING AB Aktieägarna i ISR Immune System Regulation Holding AB (publ) kallas härmed till årsstämma torsdagen den 9 februari 2017, kl. 14.00 på Advokatfirman [...]
The introduction of ART medicines has dramatically changed the prognosis of HIV infected patients and contributed to ease the burden of disease of patients, the patients´ families and societies.
Recent pandemic threats caused by new and old virus infections have emphasized the urgent need to develop drugs that not only target the life cycle of the virus but also boost the immune system...
According to www.clinicaltrials.gov there are more than 7 000 clinical trials that investigate various aspects of HIV infected patients including investigational research...
The immune system has been in focus to treat cancer for many years. Using the immune system to treat cancer cover a vast range of different research areas...
